Medicare Enrolled
Dr. Alfred Maksoud, MD
Pulmonary Disease · Webster, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maksoud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maksoud?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maksoud
Dr. Alfred Maksoud is a pulmonary disease specialist in Webster, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Maksoud performed 3,068 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Maksoud received a total of $16,710 from 51 pharmaceutical and/or device companies across 766 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maksoud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in TX
$16,710 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,068
Medicare services
Top 9% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
857 | $96 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
603 | $63 | $115 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
198 | $30 | $400 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
170 | $175 | $350 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
164 | $44 | $300 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
164 | $46 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
162 | $69 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
125 | $126 | $225 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
101 | $115 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
94 | $141 | $325 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
89 | $359 | $650 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
73 | $96 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
49 | $82 | $155 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
35 | $14 | $30 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
33 | $479 | $2,300 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
32 | $23 | $35 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
28 | $498 | $2,500 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
20 | $20 | $600 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
18 | $32 | $150 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
16 | $84 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $107 | $275 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
13 | $13 | $25 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
11 | $116 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,710
Total received (2018-2024)
Avg $2,387/year across 7 years
Top 13% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
766
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,087
2023
$2,793
2022
$2,674
2021
$1,646
2020
$2,420
2019
$2,891
2018
$1,199
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$517
Inspire Medical Systems, Inc.
$397
GlaxoSmithKline, LLC.
$313
Electromed, Inc.
$264
Actelion Pharmaceuticals US, Inc.
$235
Regeneron Healthcare Solutions, Inc.
$188
Insmed, Inc.
$179
GENZYME CORPORATION
$139
ABBVIE INC.
$132
Philips North America LLC
$120
Pulmonx Corporation
$89
Amgen Inc.
$78
Avadel CNS Pharmaceuticals, LLC
$70
HARMONY BIOSCIENCES LLC
$66
Mylan Specialty L.P.
$57
Mallinckrodt Hospital Products Inc.
$55
Inari Medical, Inc.
$50
United Therapeutics Corporation
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
ANI Pharmaceuticals, Inc.
$25
Axsome Therapeutics, Inc.
$25
Resmed Corp
$15
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,491
AstraZeneca Pharmaceuticals LP
$2,170
Pulmonx Corporation
$1,670
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,082
Actelion Pharmaceuticals US, Inc.
$958
Veran Medical Technologies, Inc.
$747
Harmony Biosciences LLC
$740
Regeneron Healthcare Solutions, Inc.
$679
Electromed, Inc.
$513
GENZYME CORPORATION
$455
Inspire Medical Systems, Inc.
$397
Grifols USA, LLC
$386
Philips Electronics North America Corporation
$378
Mylan Specialty L.P.
$342
Insmed, Inc.
$340
Amgen Inc.
$277
Mallinckrodt Hospital Products Inc.
$247
Sunovion Pharmaceuticals Inc.
$243
United Therapeutics Corporation
$240
Intuitive Surgical, Inc.
$227
HARMONY BIOSCIENCES LLC
$187
Novartis Pharmaceuticals Corporation
$184
ABBVIE INC.
$152
Genentech USA, Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$142
Philips North America LLC
$120
Takeda Pharmaceuticals U.S.A., Inc.
$105
JAZZ PHARMACEUTICALS INC.
$102
Shionogi Inc
$102
Tactile Systems Technology Inc
$97
Teva Pharmaceuticals USA, Inc.
$97
Avadel CNS Pharmaceuticals, LLC
$95
PFIZER INC.
$85
Jazz Pharmaceuticals Inc.
$78
Merck Sharp & Dohme LLC
$55
Inari Medical, Inc.
$50
Circassia Pharmaceuticals Inc
$42
Resmed Corp
$39
Allergan, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
ANI Pharmaceuticals, Inc.
$25
Baxter Healthcare
$25
Axsome Therapeutics, Inc.
$25
Gilead Sciences, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$19
Inogen, Inc.
$17
Advanced Respiratory, Inc
$13
Phadia US Inc.
$13
Allergan Inc.
$11
Janssen Pharmaceuticals, Inc
$10
bioMerieux
$9
Top 3 companies account for 37.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · CINQAIR · CT THROMBECTOMY SYSTEM KIT · DALVANCE · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Fetroja · Flexitouch Plus · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INSPIRE · ImmunoCAP · InogenOne · LONHALA MAGNAIR · LUMRYZ · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · REMODULIN · Repatha · Respiratoriy Care Undiv · S · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Spin · Sunosi · TAVNEOS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · VIDAS BRAHMS PCT · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
102
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maksoud is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maksoud experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maksoud performed 857 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Maksoud receive payments from pharmaceutical companies?
Yes. Dr. Maksoud received a total of $16,710 from 51 companies across 766 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maksoud's costs compare to other pulmonary diseases in Webster?
Dr. Maksoud's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maksoud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Webster
Browse pulmonary diseases in Webster ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology